机译:比较有单一不可治愈因素的晚期胃癌患者行胃癌切除术加化学疗法与单独化疗的随机对照试验:日本临床肿瘤学小组研究JCOG 0705和韩国胃癌协会研究KGCA01
Department of Surgery National Osaka Medical Center Osaka Japan;
Department of Surgery Cancer Research Institute Seoul National University;
Department of Surgery Seoul National University Bundang Hospital;
Department of Preventive Medicine Seoul National University Seoul Republic of Korea;
Center for Cancer Control and Information Services National Cancer Center Tokyo Japan;
Department of Surgery Yonsei University Severance Hospital Seoul Republic of Korea;
Department of Gastrointestinal Oncology Shizuoka Cancer Center Shizuoka Japan;
Department of Medical Oncology Seoul National University Seoul Republic of Korea;
Department of Surgery Hyogo Medical College Hyogo Japan;
Department of Surgery Korea Cancer Center Seoul Republic of Korea;
机译:将胃切除术加化学疗法与仅化学疗法治疗晚期胃癌的单一不可治愈因素进行比较的随机对照试验:日本临床肿瘤学小组研究JCOG 0705和韩国胃癌协会研究KGCA01。
机译:胃切除术加化学药物治疗与单纯化学治疗晚期胃癌伴单一不可治愈因子(REGATTA):3期随机对照试验
机译:一期II / III随机对照试验比较围手术期与MfolfoX6术后化疗,用于疑似侧骨盆节点转移的下直肠癌:日本临床肿瘤学研究JCOG1310(珍贵的研究)
机译:日本晚期胃癌化疗的证据与临床实践
机译:晚期胃癌患者化学疗法的治疗模式和成本效益
机译:II / III期随机对照试验比较了使用mFOLFOX6进行围手术期化疗与术后化疗与可疑盆腔外侧转移的下直肠癌的比较:日本临床肿瘤学小组研究JCOG1310(PRECIOUS研究)
机译:II / III期随机对照试验比较围手术期与MFOLFOX6术后化疗,用于疑似侧腹腹部转移的下直肠癌:日本临床肿瘤学研究JCOG1310(珍贵的研究)